#washingtonexaminer #ozempic #alcohol #opioids #addictiontreatment #health #healthcare
A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder.
This is the second study this fall to suggest that GLP-1s, such as Novo Nordisk’s Ozempic and Wegovy or Eli Lilly’s Mounjaro and Zepbound, have the ability to revolutionize the drug treatment options for people addicted to drugs or alcohol.
Read the full story here:
https://www.washingtonexaminer.com/policy/healthcare/3193411/ozempic-could-help-opioid-alcohol-abuse-new-research-shows/
Check out our website:
https://www.washingtonexaminer.com/
){kind=link}
Comments
Comments are disabled for this post.